phenytoin has been researched along with quinazolines in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Combs, G; Diamond, L; Glasser, AC | 1 |
| Blaschke, TF; Giacomini, KM; Luttrell, S; Schulz, P; Turner-Tamiyasu, K | 1 |
| Abang, A; Blaschke, TF; Giacomini, JC; Giacomini, KM; Schulz, P | 1 |
| Maitra, SC; Mukherjee, SK; Murthi, PS; Rastogi, AK | 1 |
| Blaschke, TF; Giacomini, JC; Giacomini, KM | 1 |
| Gabizon, A; Gipps, M; Grenader, T; Shavit, L | 1 |
| Becquemont, L; Bergmann, JF; Chhun, S; Mouly, S; Peretti, I; Rizzo-Padoin, N; Simoneau, G; Swaisland, A; Verstuyft, C; Wortelboer, R | 1 |
| Daniels, MA; George, AL; Kahlig, KM; Porter, JC; Thompson, CH | 1 |
1 trial(s) available for phenytoin and quinazolines
| Article | Year |
|---|---|
Gefitinib-phenytoin interaction is not correlated with the C-erythromycin breath test in healthy male volunteers.
Topics: Adolescent; Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breath Tests; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Drug Interactions; Epidemiologic Methods; Gefitinib; Genotype; Humans; Male; Middle Aged; Phenytoin; Protein Kinase Inhibitors; Quinazolines; Young Adult | 2009 |
7 other study(ies) available for phenytoin and quinazolines
| Article | Year |
|---|---|
Synthesis and anticonvulsant activity of substituted 2-thioquinazolin-4-ones. I. Preliminary studies.
Topics: Animals; Anticonvulsants; Chemical Phenomena; Chemistry; Electroshock; Male; Mice; Pentylenetetrazole; Phenobarbital; Phenytoin; Quinazolines; Seizures | 1971 |
Effect of low doses of heparin on the plasma binding of phenytoin and prazosin in normal man.
Topics: Adult; Erythrocytes; Fatty Acids, Nonesterified; Heparin; Humans; Male; Phenytoin; Prazosin; Protein Binding; Quinazolines; Triglycerides | 1983 |
Effect of heparin on the red blood cell-to-plasma concentration ratio of diphenylhydantoin and prazosin.
Topics: Erythrocytes; Fatty Acids, Nonesterified; Female; Heparin; Humans; Male; Middle Aged; Phenytoin; Plasma; Prazosin; Quinazolines | 1983 |
Diphenylhydantoin protection of centpiperalone induced insulin release from beta-cells.
Topics: Animals; Blood Glucose; Cytoplasmic Granules; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Phenytoin; Piperazines; Piperidines; Quinazolines; Quinazolinones; Rats | 1980 |
Absence of effect of heparin on the binding of prazosin and phenytoin to plasma proteins.
Topics: Blood Proteins; Fatty Acids, Nonesterified; Heparin; Humans; Hydrolysis; In Vitro Techniques; Lipase; Phenytoin; Prazosin; Quinazolines | 1980 |
Significant drug interaction: phenytoin toxicity due to erlotinib.
Topics: Anticonvulsants; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Interactions; Erlotinib Hydrochloride; Fatal Outcome; Female; Humans; Lung Neoplasms; Middle Aged; Phenytoin; Protein Kinase Inhibitors; Quinazolines; Seizures | 2007 |
Nontruncating SCN1A mutations associated with severe myoclonic epilepsy of infancy impair cell surface expression.
Topics: Alleles; Amino Acid Sequence; Amino Acid Substitution; Anticonvulsants; Cell Membrane; Epilepsies, Myoclonic; Gene Expression Regulation; HEK293 Cells; Humans; Lamotrigine; Mutation, Missense; NAV1.1 Voltage-Gated Sodium Channel; Phenytoin; Piperazines; Quinazolines; Sequence Deletion; Triazines | 2012 |